Blue Highway president and CEO, Al Di Rienzo, presented at the Rehabilitation Research and Training Institute (RRTI) on February 9, 2012. Di Rienzo’s session, broadcast via teleconference, was focused on topics related to telemedicine and nursing. The training session was designed to support the professional development of LPNs, RNs, Nurse Practitioners, and Nurse Managers. Overall, approximately 400 nurses were in attendance of the teleconference across New York State.

Di Rienzo’s session topics included remote patient monitoring, state-of-the-art telehealth, nursing informatics, and the future of telemedicine. The goal of his session was to discuss the multiple uses of telemedicine and the applications of telehealth in a clinical setting. In addition, Di Rienzo described the current uses of telepsychiatry by nurses with individuals with developmental disabilities statewide.

The RRTI will present a total of 11 Nurse Training Program sessions across New York State, all with a focus on training nurses in pharmacology, telemedicine, and developmental disabilities. The program offers these classes for free, as the funding is provided by the Health Resources and Services Administration (HRSA) of the United States Department of Health and Human Services. For more information or how to register, visit www.rrti.org

Blue Highway President and CEO, Al Di Rienzo, was featured on CEO Hour, a radio show that speaks with successful CEOs about their business and seeks advice for other business leaders, hosted by Bruce Peters and Diana Palotas. Di Rienzo discussed the history of Blue Highway and why other companies can benefit from hiring an external consultancy to research and develop ideas and innovation. Blue Highway’s unique idea vetting process can provide both small and large companies with the developmental services needed to bring ideas to market.

Di Rienzo discussed some of the current projects worked on by the Blue Highway team. Researchers are working with Welch Allyn to develop a non-invasive, early, visual screening test predictor for Alzheimer’s. This screener will be able to detect visual bio markers prior to the onset of the disease. Blue Highway is taking game-changing ideas through proof of concept and clinical studies.

The culture at Blue Highway is what allows creativity and innovation to flow. There is a freedom to incubate idea and foster ingenuity, while everyone is working toward the same goal, the betterment of society. No one employee is isolated as everyone is willing to be collaborative. For more information about Blue Highway, click here.

To listen to Al’s conversation about Blue Highway, please click the following links:

Part 1           Part 2            Part 3

Smart medical devices are the wave of the future. They are aimed to advance the American healthcare system, and these devices present the opportunity to change the perception of modern medicine. Several factors make Smart devices better than any other: they’re smarter, more connected, and provide the right context for medical situations, proving to be the most cost-effective solution.

• SMART: Smart devices will eliminate the mental and physical steps of transcribing data into patient medical records. Communication failures and human errors in care delivery will be drastically reduced.
• CONNECTED: As health insurance becomes nearly universal, a Smart device will make information more accessible, optimize disease management, identify best practices, and educate patients about their health status. Resources will be used more efficiently and sustainably, producing better health outcomes at all levels of care.
• CONTEXTUAL: A Smart device will be able to perform a situational analysis of the patient at a given time. Providing the proper context in a healthcare situation greatly reduces the margin of error and eliminates fallacies.

Blue Highway President and CEO, Albert J. Di Rienzo, was appointed Professor of Forensic Science in the Forensic and National Security Sciences Institute (FNSSI) at Syracuse University on January 26, 2012. As recognition of Di Rienzo’s significant professional accomplishments, the three-year appointment will begin immediately with the goal of fostering collaboration between industry and academia.

Di Rienzo will have the opportunity to offer courses and lectures, and work in collaboration with both students and faculty from the Institute. The professorship was appointed by James Spencer, Associate Dean for Science, Mathematics, and Research and Executive Director of FNSSI, in concurrence with George Langford, Dean of the College of Arts and Sciences at Syracuse University. For more information about the Forensic and National Security Sciences Institute, visit forensics.syr.edu

About Blue Highway, Inc.

Since its founding in 2008, Blue Highway has been affiliated with Syracuse University. Blue Highway is an industry-leading healthcare and technology company, specializing in the research, engineering, and commercialization of novel ideas. Through an advanced triage process across many disciplines, Blue Highway provides clients with translational services. In addition to specializing in the medical and healthcare fields, Blue Highway is experienced in sensing, signal processing, and advanced analytics.